Broadfin Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Broadfin Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$3.45M	–	53
2019 Q3	$3.45M	Buy	+30,000	New	+$4.55M	0.64%	36
2018 Q2	–	Sell	-175,030	Closed	-$19.7M	–	62
2018 Q1	$19.7M	Buy	175,030 +52,100	+42%	+$6.55M	3.07%	11
2017 Q4	$16.2M	Buy	+122,930	New	+$14.4M	2.65%	17
2013 Q4	–	Sell	-332,936	Closed	-$5.7M	–	70
2013 Q3	$5.7M	Buy	332,936 +52,936	+19%	+$608K	1.01%	30
2013 Q2	$2.47M	Buy	+280,000	New	+$2.48M	0.48%	41

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Broadfin Capital's GWPH Position: Q4 2019 in Review

Broadfin Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 30,000 shares — an estimated $3.45M sold.

Broadfin Capital first reported a position in GWPH in Q2 2013 and held it in 5 quarters. The position peaked at $19.7M in Q1 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Broadfin Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Broadfin Capital sold 30,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $3.45M.
Broadfin Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 5 quarters.
Broadfin Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $19.7M in Q1 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Broadfin Capital's 13F filing for Q4 2019, filed 14 Feb 2020.